Amanote Research
Register
Sign In
Hepatic Progenitor Cell Inhibition During Embryonic Period With High Dose Verapamil; Liable Joint to the Cancer Therapy
Bratislava Medical Journal
doi 10.4149/bll_2013_079
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 2013
Authors
S. Uslu
A. Uysal
A. Bilir
B.C. Soner
G. Oktem
Publisher
AEPress, s.r.o.
Related search
Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34+Bone Marrow Mononuclear Cells
Stem Cells International
Cell Biology
Molecular Biology
Embryonic Origin and Hox Status Determine Progenitor Cell Fate During Adult Bone Regeneration
Development (Cambridge)
Developmental Biology
Molecular Biology
Is High Dose Therapy Superior to Conventional Dose Therapy as Initial Treatment for Relapsed Germ Cell Tumors? The TIGER Trial
Journal of Cancer
Oncology
High-Dose Therapy With Autologous Stem Cell Transplantation in Patients With Peripheral T Cell Lymphomas
Bone Marrow Transplantation
Transplantation
Hematology
FGF2 Mediates Hepatic Progenitor Cell Formation During Human Pluripotent Stem Cell Differentiation by Inducing the WNT Antagonist NKD1
Genes and Development
Genetics
Developmental Biology
ATM Inhibition Sensitizes Tumors to High-Dose Irradiation
Cancer Research
Cancer Research
Oncology
Repetitive High-Dose Therapy With Cyclophosphamide, Thiotepa and Docetaxel With Peripheral Blood Progenitor Cell and Filgrastim Support for Metastatic and Locally Advanced Breast Cancer: Results of a Phase I Study
Bone Marrow Transplantation
Transplantation
Hematology
Effective T Cell Regeneration Following High-Dose Chemotherapy Rescued With CD34+ Cell Enriched Peripheral Blood Progenitor Cells in Children
Bone Marrow Transplantation
Transplantation
Hematology
High Dose Chemotherapy With Peripheral Blood Stem Cell Transplantation for Small Cell Lung Cancer.
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
